Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.

Lacout, Alexis; Lounnas, Valere; Perronne, Christian

Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.

Lacout, Alexis; Lounnas, Valere; Perronne, Christian.

Afiliação

Lacout A; Centre de diagnostic, ELSAN, Centre médico-chirurgical, Aurillac France. Electronic address: lacout.alexis@wanadoo.fr.
Lounnas V; EMBL Heidelberg Alumni, Heidelberg, Germany.
Perronne C; Infectious Diseases Unit, University Hospital Raymond Poincaré, APHP, Versailles Saint Quentin University, Garches, France.

Int J Antimicrob Agents ; 57(4): 106314, 2021 04.

Article em En | MEDLINE | ID: mdl-33722657

Assuntos

Tratamento Farmacológico da COVID-19; Hidroxicloroquina; Idoso; Azitromicina; Quimioterapia Combinada; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google